Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases
Authors
Keywords
-
Journal
FEBS LETTERS
Volume 585, Issue 23, Pages 3699-3709
Publisher
Wiley
Online
2011-03-17
DOI
10.1016/j.febslet.2011.03.023
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A case report of a patient with refractory adult-onset Still’s disease who was successfully treated with tocilizumab over 6 years
- (2014) Hideko Nakahara et al. Modern Rheumatology
- Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy
- (2014) Norihiro Nishimoto et al. Modern Rheumatology
- Mixed response to tocilizumab for ankylosing spondylitis
- (2010) J. C. Henes et al. ANNALS OF THE RHEUMATIC DISEASES
- Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA
- (2010) J. L. Nam et al. ANNALS OF THE RHEUMATIC DISEASES
- Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study
- (2010) Gabor G. Illei et al. ARTHRITIS AND RHEUMATISM
- Mechanisms Underlying Inflammation in Neurodegeneration
- (2010) Christopher K. Glass et al. CELL
- Etanercept-refractory adult-onset Still’s disease with thrombotic thrombocytopenic purpura successfully treated with tocilizumab
- (2010) Keiichi Sumida et al. CLINICAL RHEUMATOLOGY
- A case of refractory adult-onset Still’s disease successfully controlled with tocilizumab and a review of the literature
- (2010) Katja Perdan-Pirkmajer et al. CLINICAL RHEUMATOLOGY
- Excellent therapeutic effect of tocilizumab on intestinal amyloid a deposition secondary to active rheumatoid arthritis
- (2010) Daichi Inoue et al. CLINICAL RHEUMATOLOGY
- IL-6: Regulator of Treg/Th17 balance
- (2010) Akihiro Kimura et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses
- (2010) Satoshi Hohki et al. EXPERIMENTAL EYE RESEARCH
- Tocilizumab: molecular intervention therapy in children with systemic juvenile idiopathic arthritis
- (2010) Shumpei Yokota et al. Expert Review of Clinical Immunology
- Tocilizumab for the treatment of rheumatoid arthritis
- (2010) Toshio Tanaka et al. Expert Review of Clinical Immunology
- Current understanding and management of giant cell arteritis and polymyalgia rheumatica
- (2010) Parasar Ghosh et al. Expert Review of Clinical Immunology
- IL-6: from its discovery to clinical applications
- (2010) T. Kishimoto INTERNATIONAL IMMUNOLOGY
- Enhanced IL-6 Production in Aquaporin-4 Antibody Positive Neuromyelitis Optica Patients
- (2010) Sema İİçöz et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Short-term effect of IL-6 inhibition in spondylarthritis
- (2010) Daniel Wendling et al. JOINT BONE SPINE
- Tocilizumab in a patient with ankylosing spondylitis and Crohn's disease refractory to TNF antagonists
- (2010) Laure Brulhart et al. JOINT BONE SPINE
- Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation
- (2010) Shigeru Kotake et al. JOURNAL OF BONE AND MINERAL RESEARCH
- A look at autoimmunity and inflammation in the eye
- (2010) Rachel R. Caspi JOURNAL OF CLINICAL INVESTIGATION
- Effectiveness and Safety of Tocilizumab, an Anti–Interleukin-6 Receptor Monoclonal Antibody, in a Patient With Refractory GI Graft-Versus-Host Disease
- (2010) Usama Gergis et al. JOURNAL OF CLINICAL ONCOLOGY
- Tocilizumab Ameliorates Clinical Symptoms in Polymyalgia Rheumatica
- (2010) K. HAGIHARA et al. JOURNAL OF RHEUMATOLOGY
- A role for IL-27p28 as an antagonist of gp130-mediated signaling
- (2010) Jason S Stumhofer et al. NATURE IMMUNOLOGY
- AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance
- (2010) Sven Jarius et al. Nature Reviews Neurology
- Immunotherapy of myositis: issues, concerns and future prospects
- (2010) Marinos C. Dalakas Nature Reviews Rheumatology
- The effect of tocilizumab on the uptake of 18FDG-PET imaging in patients with adult-onset Still's disease
- (2010) M. L. Cunha et al. RHEUMATOLOGY
- The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab
- (2010) Y. Shima et al. RHEUMATOLOGY
- Circulating cytokines in active polymyalgia rheumatica
- (2009) L Alvarez-Rodriguez et al. ANNALS OF THE RHEUMATIC DISEASES
- Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study
- (2009) G. Jones et al. ANNALS OF THE RHEUMATIC DISEASES
- Rapid improvement of AA amyloidosis with humanised anti-interleukin 6 receptor antibody treatment
- (2009) S Nishida et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)
- (2009) O Kowal-Bielecka et al. ANNALS OF THE RHEUMATIC DISEASES
- Successful treatment of reactive arthritis with a humanized antiâinterleukin-6 receptor antibody, tocilizumab
- (2009) Toshio Tanaka et al. ARTHRITIS AND RHEUMATISM
- Therapeutic effects of interleukin-6 blockade in a murine model of polymyositis that does not require interleukin-17A
- (2009) Naoko Okiyama et al. ARTHRITIS AND RHEUMATISM
- IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
- (2009) Sergei Grivennikov et al. CANCER CELL
- Glucocorticoid and cyclosporine refractory adult onset Still’s disease successfully treated with tocilizumab
- (2009) Kazuko Matsumoto et al. CLINICAL RHEUMATOLOGY
- Tocilizumab dramatically ameliorated life-threatening diarrhea due to secondary amyloidosis associated with rheumatoid arthritis
- (2009) Hiroe Sato et al. CLINICAL RHEUMATOLOGY
- Behçet's disease – a contemporary review
- (2009) Daniela Mendes et al. JOURNAL OF AUTOIMMUNITY
- The IL-27 p28 Subunit Binds Cytokine-Like Factor 1 to Form a Cytokine Regulating NK and T Cell Activities Requiring IL-6R for Signaling
- (2009) S. Crabe et al. JOURNAL OF IMMUNOLOGY
- Scleroderma
- (2009) Armando Gabrielli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of a patient with remitting seronegative, symmetrical synovitis with pitting oedema with a humanized anti-interleukin-6 receptor antibody, tocilizumab
- (2009) T. Tanaka et al. RHEUMATOLOGY
- Monitoring of therapeutic efficacy in a patient with RS3PE syndrome by serologic variables and radiographic methods
- (2009) Shin-ya Kawashiri et al. RHEUMATOLOGY INTERNATIONAL
- Tocilizumab for multirefractory adult-onset Still's disease
- (2008) M De Bandt et al. ANNALS OF THE RHEUMATIC DISEASES
- IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
- (2008) P. Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study
- (2008) Mark C. Genovese et al. ARTHRITIS AND RHEUMATISM
- Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses
- (2008) Minoru Fujimoto et al. ARTHRITIS AND RHEUMATISM
- Successful treatment of a patient with takayasu arteritis using a humanized anti-interleukin-6 receptor antibody
- (2008) Norihiro Nishimoto et al. ARTHRITIS AND RHEUMATISM
- Adult-onset Still disease
- (2008) Bruno Fautrel BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease
- (2008) N. Nishimoto et al. BLOOD
- Giant cell arteritis and polymyalgia rheumatica: Role of cytokines in the pathogenesis and implications for treatment
- (2008) Victor Manuel Martinez-Taboada et al. CYTOKINE
- Nuanced roles of cytokines in three major human brain disorders
- (2008) Lawrence Steinman JOURNAL OF CLINICAL INVESTIGATION
- Reiter's syndrome: The classic triad and more
- (2008) Ines B. Wu et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Polymyalgia rheumatica and giant-cell arteritis
- (2008) Carlo Salvarani et al. LANCET
- Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
- (2008) Josef S Smolen et al. LANCET
- Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial
- (2008) Shumpei Yokota et al. LANCET
- IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis
- (2008) Satoshi Serada et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More